You are here: Industry Insights > COVID-19

News List

Whole-town study reveals more than 40% of COVID-19 infections had no symptoms worldpharmanews
July 01, 2020
A study of COVID-19 in the quarantined Italian town of Vò, where most of the population was tested, reveals the importance of asymptomatic cases.
Noxopharm reports Covid-19 trial programme to commence in Europe pharmaceutical-business-review
July 01, 2020
Noxopharm, a clinical-stage Australian drug development company, has announced commencement of its NOXCOVID clinical program with a planned Phase I trial in Europe.
FDA to Harness Real-World Data to Inform COVID-19 Response Efforts americanpharmaceuticalreview
July 01, 2020
The U.S. Food and Drug Administration (FDA) has taken an additional step in harnessing real-world data to help inform the agency’s overall response to the COVID-19 public health emergency.
Ajinomoto Bio-Pharma Introduces AJILITY Fast Track Platform for Drug Product Manufacturing americanpharmaceuticalreview
July 01, 2020
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY?, a flexible and agile drug product manufacturing platform, designed to advance vaccines and therapies to market by minimizing time to production.
Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations expresspharma
July 01, 2020
Remdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19.
UK regulator says COVID-19 prevention trial of hydroxychloroquine can resume expresspharma
July 01, 2020
The decision came after the drug was found in another UK trial to have no benefit for patients already infected with COVID-19, the pandemic disease caused by the new coronavirus.
Genetics has revolutionised patient selection for clinical trials expresspharma
July 01, 2020
How is genetics improving the sphere of drug discovery and development? In what ways has it helped in clinical research, target identification, drug safety testing, etc.? Give us a few real-world examples.
Researchers identify drugs that may block cell to cell transmission of coronavirus expresspharma
July 01, 2020
The scientists analysed all host and viral proteins that showed changes in an enzymatic process called phosphorylation after SARS-CoV-2 infection.
Scottish firm to trial T cells as possible COVID-19 treatment expresspharma
July 01, 2020
TC BioPharm (TCB) said it would conduct the trial at the Edinburgh Royal Infirmary, using gamma-delta T cells in a technique it has previously used on cancer patients.
Theravance Biopharma doses first patient in phase 2 Covid-19 trial with JAKi inhibitor TD-0903 pharmaceutical-business-review
June 30, 2020
Theravance Biopharma has dosed the first patient in the phase 2 study of lung-selective and nebulized Janus kinase inhibitor (JAKi) TD-0903 to treat hospitalised patients with acute lung injury (ALI) due to Covid-19.